HURN Stock Analysis: Huron Consulting | NASDAQ
Consulting Services | NASDAQ, USA | Market Cap: 1.826m USD | 12M Return: -14.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 31.1M
EPS Trend: 99.2%
Qual. Beats: 3
Rev. Trend: 99.2%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Huron Consulting Group Inc. (NASDAQ: HURN) is a global professional services firm headquartered in Chicago, Illinois, operating through three segments: Healthcare, Education, and Commercial. The company delivers a broad range of consulting, managed services, and software solutions, including financial and operational performance improvement, digital and technology services (such as enterprise systems, data management, and AI/automation), revenue cycle outsourcing, regulatory and risk consulting, and strategy and innovation advisory. It also offers the Huron Research product suite, a software platform supporting research administration and compliance, primarily for academic and healthcare institutions. Hurons client base spans healthcare, education, financial services, industrials and manufacturing, energy and utilities, and the public sector.
As a small-cap stock in the Industrials sector, Huron competes within the GICS Research & Consulting Services sub-industry, a fragmented market where revenue is typically generated through billable consulting hours, multi-year managed service contracts, and recurring software licensing. The companys combination of traditional advisory services with proprietary software products reflects a broader industry trend among professional services firms seeking to diversify revenue streams beyond labor-based engagements.
- Healthcare digital outsourcing demand accelerates segment revenue growth
- University budget cuts pressure Education segment consulting revenue
- Share repurchases and acquisitions bolster EPS expansion
| Net Income: 103.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -7.24 > 1.0 |
| NWC/Revenue: 16.26% < 20% (prev 14.97%; Δ 1.29% < -1%) |
| CFO/TA 0.09 > 3% & CFO 138.1m > Net Income 103.8m |
| Net Debt (893.7m) to EBITDA (221.8m): 4.03 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.4m) vs 12m ago -5.79% < -2% |
| Gross Margin: 30.56% > 18% (prev 32.18%; Δ -1.62% > 0.5%) |
| Asset Turnover: 117.7% > 50% (prev 111.9%; Δ 5.79% > 0%) |
| Interest Coverage Ratio: 5.00 > 6 (EBIT TTM 187.3m / Interest Expense TTM 37.4m) |
| A: 0.18 (Total Current Assets 514.7m - Total Current Liabilities 232.2m) / Total Assets 1.59b |
| B: 0.38 (Retained Earnings 608.3m / Total Assets 1.59b) |
| C: 0.13 (EBIT TTM 187.3m / Avg Total Assets 1.48b) |
| D: 0.33 (Book Value of Equity 397.4m / Total Liabilities 1.19b) |
| Altman-Z'' = 3.62 = AA |
| DSRI: 1.02 (Receivables 453.0m/388.4m, Revenue 1.74b/1.53b) |
| GMI: 1.05 (GM 32.18% / 30.56%) |
| AQI: 1.00 (AQ_t 0.65 / AQ_t-1 0.65) |
| SGI: 1.14 (Revenue 1.74b / 1.53b) |
| TATA: -0.02 (NI 103.8m - CFO 138.1m) / TA 1.59b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of July 22, 2026, the stock is trading at USD 110.85 with a total of 337,141 shares traded. Over the past week, the price has changed by +1.01%, over one month by +22.51%, over three months by -13.59% and over the past year by -14.87%.
Current recommended Stop Loss: 95.80 (which is 13.6% or 2.7 ATR below the current price).
Huron Consulting has received a consensus analysts rating of 4.80. Therefore, it is recommended to buy HURN.
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 184.3 | 66.2% |
P/E Trailing = 19.6562
P/E Forward = 13.459
P/S = 1.0673
P/B = 4.684
P/EG = 1.5199
Revenue TTM = 1.74b USD
EBIT TTM = 187.3m USD
EBITDA TTM = 221.8m USD
Long Term Debt = 834.7m USD (from longTermDebt, last quarter)
Short Term Debt = 31.2m USD (from shortTermDebt, last quarter)
Debt = 920.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 32.7m
Net Debt = 893.7m USD (calculated: Debt 920.1m - CCE 26.5m)
Enterprise Value = 2.72b USD (1.83b + Debt 920.1m - CCE 26.5m)
Interest Coverage Ratio = 5.00 (Ebit TTM 187.3m / Interest Expense TTM 37.4m)
EV/FCF = 23.12x (Enterprise Value 2.72b / FCF TTM 117.6m)
FCF Yield = 4.32% (FCF TTM 117.6m / Enterprise Value 2.72b)
FCF Margin = 6.77% (FCF TTM 117.6m / Revenue TTM 1.74b)
Net Margin = 5.97% (Net Income TTM 103.8m / Revenue TTM 1.74b)
Gross Margin = 30.56% ((Revenue TTM 1.74b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 27.85% (prev 30.98%)
Tobins Q-Ratio = 1.71 (Enterprise Value 2.72b / Total Assets 1.59b)
Interest Expense / Debt = 4.07% (Interest Expense 37.4m / Debt 920.1m)
Taxrate = 26.26% (36.9m / 140.7m)
NOPAT = 138.1m (EBIT 187.3m * (1 - 26.26%))
Current Ratio = 2.22 (Total Current Assets 514.7m / Total Current Liabilities 232.2m)
Debt / Equity = 2.32 (Debt 920.1m / totalStockholderEquity, last quarter 397.4m)
Debt / EBITDA = 4.03 (Net Debt 893.7m / EBITDA 221.8m)
Debt / FCF = 7.60 (Net Debt 893.7m / FCF TTM 117.6m)
Total Stockholder Equity = 475.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.03% (Net Income 103.8m / Total Assets 1.59b)
RoE = 21.83% (Net Income TTM 103.8m / Total Stockholder Equity 475.2m)
RoCE = 14.30% (EBIT 187.3m / Capital Employed (Equity 475.2m + L.T.Debt 834.7m))
RoIC = 10.14% (NOPAT 138.1m / Invested Capital 1.36b)
WACC = 5.71% (E(1.83b)/V(2.75b) * Re(7.08%) + D(920.1m)/V(2.75b) * Rd(4.07%) * (1-Tc(0.26)))
Discount Rate = 7.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.77 | Cagr: -4.68%
[DCF] Terminal Value 73.10% ; FCFF base≈150.4m ; Y1≈131.9m ; Y5≈106.6m
[DCF] Fair Price = 50.38 (EV 1.71b - Net Debt 893.7m = Equity 816.8m / Shares 16.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 99.21 | EPS CAGR: 25.47% | SUE: 0.89 | # QB: 3
Revenue Correlation: 99.20 | Revenue CAGR: 11.19% | SUE: 1.04 | # QB: 3
EPS current Quarter (2026-06-30): EPS=2.17 | Chg30d=+0.00% | Revisions=+0% | Analysts=5
EPS next Quarter (2026-09-30): EPS=2.43 | Chg30d=+0.00% | Revisions=-12% | Analysts=5
EPS current Year (2026-12-31): EPS=8.84 | Chg30d=+0.00% | Revisions=+12% | GrowthEPS=+12.8% | GrowthRev=+9.9%
EPS next Year (2027-12-31): EPS=10.22 | Chg30d=+0.00% | Revisions=+38% | GrowthEPS=+15.6% | GrowthRev=+8.3%
[Analyst] Revisions Ratio: +14% (up=11, down=8)